Zocaglusagene Nuzaparvovec
Chemical
FDA Substance Registry (openFDA)
Learn more about this substance:
Ask ChatGPT
Google
PubChem
Wikipedia
EWG Skin Deep
INCIDecoder
ECHA
Chemical Identification
| CAS Number | 2601264-52-0 |
|---|
Known Aliases (6)
Common Name
AT-845
AT845
DNA (recombinant adeno-associated virus vector AT845 mouse muscle-type creatine kinase enhancer plus mouse muscle-type creatine kinase promoter plus human lysosomal α-glucosidase precursor codon-optimized transgene plus simian virus 40 polyadenylation signal plus adeno-associated virus 2 inverted terminal repeat flanks-specifying)
Recombinant, non-replicating adeno-associated virus serotype 8 (rAAV8) vector encoding codon-optimized human acid alpha-glucosidase (GAA), also called lysosomal α-glucosidase or acid maltase, under control of a mouse muscle creatine kinase (MCK) enhancer/promoter followed by a simian virus 40 (SV40) intron, terminated by the SV40 late polyadenylation sequence, and flanked by AAV2 inverted terminal repeats (ITRs)
zocaglusagene nuzaparvovec [INN]
ZOCAGLUSAGENE NUZAPARVOVEC [USAN]
Data Sources (1)
| Source | Source ID | Name in Source | Properties |
|---|---|---|---|
| FDA Substance Registry (openFDA) | FDB4GQ8A3Y |
Zocaglusagene Nuzaparvovec |
CAS: 2601264-52-0 INN: 12248 USAN: LM-146 SMS_ID: 300000044947 FDA UNII: FDB4GQ8A3Y NCI_THESAURUS: C190444 |
Record Info
| ID | MCXPyv7fn88uVNBX4e8RvS |
|---|---|
| Created | April 10, 2026, 8:13 p.m. |
| Modified | April 11, 2026, 12:27 a.m. |
| Data Source | FDA Substance Registry (openFDA) |